Imbalance between pro-oxidant and pro-antioxidant functions of zinc in disease

Journal of Alzheimer's Disease

Volumn 8, Issue 2, 2005, Pages 161-170

  Hao, Qiang ^a   Maret, Wolfgang ^a,b  

^a University of Texas Medical Branch School of Medicine   (United States)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Alzheimer's Disease; AP 1; Metallothionein thionein; NF B; Oxidative stress; p53; Zinc

Indexed keywords

ANTIOXIDANT; APOLIPOPROTEIN A1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; METALLOTHIONEIN; PROTEIN P53; ZINC FINGER PROTEIN;

ALZHEIMER DISEASE; CELL ACTIVITY; CELL DEATH; DISEASE ASSOCIATION; HUMAN; METAL METABOLISM; MITOCHONDRION; MOLECULAR BIOLOGY; NERVE CELL; NITROSATION; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; REVIEW; SIGNAL TRANSDUCTION; ZINC DEFICIENCY; ZINC FINGER MOTIF;

EID: 32544452896     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2005-8209     Document Type: Review

References (118)

1. F.M. Burnet, A possible role of zinc in the pathology of dementia, Lancet 1 (1981), 186-188.
2. B.L. Vallee and K.H. Falchuk, The biochemical basis of zinc physiology, Physiol Rev 73 (1993), 79-118.
3. C.J. Frederickson, J.Y. Koh and A.I. Bush, The neurobiology of zinc in health and disease, Nat Rev Neurosci 6 (2005), 449-462.
4. K. Wang, B. Zhou, Y.M. Kuo, J. Zemansky and J. Gitschier, A novel member of a zinc transporter family is defective in Acrodermatitis enteropathica, Am J Hum Genet 71 (2002), 66-73.
5. S. Kury, B. Dreno, S. Bezieau, S. Giraudet, M. Kharfi, R. Kamoun and J.P. Moisan, Identification of SLC39A4, a gene involved in Acrodermatitis enteropathica, Nat Genet 31 (2002), 239-240.
6. H.H. Sandstead, Zinc is essential for brain development and function, J Trace Elem Exp Med 16 (2003), 165-173.
7. C.J. Frederickson, Neurobiology of zinc and zinc-containing neurons, Int Rev Neurobiol 31 (1989), 145-238.
8. C.J. Frederickson and A.I. Bush, Synaptically released zinc: physiological functions and pathological effects, Biometals 14 (2001), 353-366.
9. A.I. Bush, The metallobiology of Alzheimer's disease, Trends Neurosci 26 (2003), 207-214.
10. M.A. Lovell, J.D. Robertson, W.J. Teesdale, J.L. Campbell and W.R. Markesbery, Copper, iron, and zinc in Alzheimer's disease senile plaques, J Neurol Sci 158 (1998), 47-52.
11. P.I. Moreira, S.L. Siedlak, G. Aliev, X. Zhu, A.D. Cash, M.A. Smith and G. Perry, Oxidative stress mechanisms and potential therapeutics in Alzheimer disease, J Neural Transm 112 (2005), 921-932.
12. W. Maret, Zinc and sulfur: a critical biological partnership, Biochemistry 43 (2004), 3301-3309.
13. W. Maret and B.L. Vallee, Thiolate ligands in metallothionein confer redox activity on zinc clusters, Proc Natl Acad Sci USA 95 (1998), 3478-3482.
14. S.H. Lee and W. Maret, Redox control of zinc finger proteins: mechanisms and role in gene regulation, Antioxid Redox Signal 3 (2001), 531-534.
15. W. Maret, Zinc coordination environments in proteins determine zinc functions, J Trace Elem Med Biol (2005), available on line 3 May 2005.
16. A.T. Dinkova-Kostova, W.D. Holtzclaw and N. Wakabayashi, Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein, Biochemistry 44 (2005), 6889-6899.
17. W. Maret, The Glutathione Redox State and Zinc Mobilization from Metallothionein and other Proteins with Zinc/Sulfur Coordination Sites, in: Glutathione in the Nervous System, Taylor and Francis, C.A. Shaw, ed., Washington D.C., 1998, pp. 257-273.
18. E.J. Peck, Jr. and W.J. Ray, Jr., Metal complexes of phosphoglucomutase in vivo, J Biol Chem 246 (1971), 1160-1167.
19. T.J.B. Simons, Intracellular free zinc and zinc buffering in human red blood cells, J Membr Biol 123 (1991), 63-71.
20. J. Benters, U. Flögel, T. Schäfer, D. Leibfritz, S. Hechtenberg and D. Beyersmann, Study of the interactions of cadmium and zinc ions with cellular calcium homeostasis using 19F-NMR spectroscopy, Biochem 7322 (1997), 793-799.
21. D. Atar, P.H. Backx, M.M. Appel, W.D. Gao and E. Marban, Excitation-transcription coupling mediated by zinc influx through voltage-dependent calcium channels, J Biol Chem 270 (1995), 2473-2477.
22. P.J. Smith, M. Wiltshire, S. Davies, S.F. Chin, A.K. Campbell and R.J. Errington, DNA damage-induced [Zn(2+)](i) transients: correlation with cell cycle arrest and apoptosis in lymphoma cells, Am J Physiol Cell Physiol 283 (2002), C609-622.
23. D.W. Choi and J.Y. Koh, Zinc and brain injury, Annu Rev Neurosci 21 (1998), 347-375.
24. S.L. Sensi, D. Ton-That, P.G. Sullivan, E.A. Jonas, K.R. Gee, L.K. Kaczmarek and J.H. Weiss, Modulation of mitochondrial function by endogenous Zn2+ pools, Proc Natl Acad Sci USA 100 (2003), 6157-6162.
25. B. Turan, H. Fliss and M. Désilets, Oxidants increase intracellular free Zn2+ concentration in rabbit ventricular myocytes, Am J Physiol 272 (1997), H2095-H2106.
26. E. Aizenman, A.K. Stout, K.A. Hartnett, K.E Dineley, B. McLaughlin and I.J. Reynolds, Induction of neuronal apoptosis by thiol oxidation: Putative role of intracellular zinc release, J Neurochem 75 (2000), 1878-1888.
27. C.M. St Croix, K.J. Wasserloos, K.E. Dineley, I.J. Reynolds, E.S. Levitan and B.R. Pitt, Nitric oxide-induced changes in intracellular zinc homeostasis are mediated by metallothionein/thionein, Am J Physiol Lung Cell Mol Physiol 282 (2002), L185-192.
28. D.U. Spahl, D. Berendji-Grün, C.V. Suschek, V. Kolb-Bachofen and K.D. Kröncke, Regulation of zinc homeostasis by inducible NO synthase-derived NO: nuclear metallothionein translocation and intranuclear Zn2+ release, Proc Natl Acad Sci USA 100 (2003), 13952-13957.
29. R.J.P. Williams, Zinc: what is its role in biology? Endeavour 8 (1984), 65-70.
30. W. Maret, C. Jacob, B.L. Vallee and E.H. Fischer, Inhibitory sites in enzymes: zinc removal and reactivation by thionein, Proc Natl Acad Sci USA 96 (1999), 1936-1940.
31. W. Maret, C.A. Yetman and L.J. Jiang, Enzyme regulation by reversible zinc inhibition: glycerol phosphate dehydrogenase as an example, Chem Biol Interact 130-132 (2001), 893-903.
32. I.G. Gazaryan, B.F. Krasnikov, G.A. Ashby, R.N. Thorneley, B.S. Kristal and A.M. Brown, Zinc is a potent inhibitor of thiol oxidoreductase activity and stimulates reactive oxygen species production by lipoamide dehydrogenase, J Biol Chem 277 (2002), 10064-10072.
33. H. Haase and W. Maret, Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling, Exp Cell Res 291 (2003), 289-298.
34. W.K. Feng, J. Cai, W.M. Pierce, R.B. Franklin, W. Maret, F.W. Benz and Y.J. Kang, Metallothionein transfers zinc to mitochondrial-aconitase through a direct interaction in mouse hearts, Biochem Biophys Res Commun 332 (2005), 853-858.
35. L.C. Costello, Y. Liu, R.B. Franklin and M.C. Kennedy, Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells, J Biol Chem 272 (1997), 28875-28881.
36. V.P. Skulachev, V.V. Chistyakov, A.A. Jasaitis and E.G. Smirnova, Inhibition of the respiratory chain by zinc ions, Biochem Biophys Res Commun 26 (1967), 1-6.
37. B. Ye, W. Maret and B.L. Vallee, Zinc metallothionein imported into liver mitochondria modulates respiration, Proc Natl Acad Sci USA 98 (2001), 2317-2322.
38. D. Jiang, P.G. Sullivan, S.L. Sensi, O. Steward and J.H. Weiss, Zn(2+) induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria, J Biol Chem 276 (2001), 47524-47529.
39. T.M. Bray and W.J. Bettger, The physiological role of zinc as an antioxidant, Free Radic Biol Med 8 (1990), 281-291.
40. S.R. Powell, The antioxidant properties of zinc, J Nutr 130 (2000), 1447S-1454S.
41. A.S. Prasad, B. Bao, F.W. Beck, O. Kucuk and F.H. Sarkar, Antioxidant effect of zinc in humans, Free Radic Biol Med 37 (2004), 1182-1190.
42. P.I. Oteiza, K.L. Olin, C.G. Fraga and C.L. Keen, Zinc deficiency causes oxidative damage to proteins, lipids and DNA in rat testes, J Nutr 125 (1995), 823-829.
43. M.P. Cuajungco and K.Y. Faget, Zinc takes the center stage: its paradoxical role in Alzheimer's disease, Brain Res Rev 41 (2003), 44-56.
44. R.J. Cousins, R.K. Blanchard, M.P. Popp, L. Liu, J. Cao, J.B. Moore and C.L. Green, A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells, Proc Natl Acad Sci USA 100 (2003), 6952-6957.
45. H. Daniel and H.T. Dieck, Nutrient-gene interactions: a single nutrient and hundreds of target genes, Biol Chem 385 (2004), 571-583.
46. P.I. Oteiza, M.S. Clegg, M.P. Zago and C.L. Keen, Zinc deficiency induces oxidative stress and AP-1 activation in 3T3 cells, Free Radic Biol Med 28 (2000), 1091-1099.
47. B. Hennig, P. Meerarani, M. Toborek and C.J. McClain, Antioxidant-like properties of zinc in activated endothelial cells, J Am Coll Nutr 18 (1999), 152-158.
48. P. Lichtlen, Y. Wang, T. Belser, O. Georgiev, U. Certa, R. Sack and W. Schaffner, Target gene search for the metal-responsive transcription factor MTF-1, Nucleic Acids Res 29 (2001), 1514-1523.
49. Y. Wang, I. Lorenzi, O. Georgiev and W. Schaffner, Metal-responsive transcription factor-1 (MTF-1) selects different types of metal response elements at low vs. high zinc concentration, Biol Chem 385 (2004), 623-632.
50. K.E. Dineley, T.V. Votyakova and I.J. Reynolds, Zinc inhibition of cellular energy production: implications for mitochondria and neurodegeneration, J Neurochem 85 (2003), 563-570.
51. + Channels, Neuron 41 (2004), 351-365.
52. Y. Yang, W. Maret and B.L. Vallee, Differential fluorescence labeling of cysteinyl clusters uncovers high tissue levels of thionein, Proc Natl Acad Sci USA 98 (2001), 5556-5559.
53. Y. Chen, Y. Irie, W.M. Keung and W. Maret, S-Nitrosothiols react preferentially with zinc thiolate clusters of metallothionein III through transnitrosation, Biochemistry 41 (2002), 8360-8367.
54. C.J. Frederickson, W. Maret and M.P. Cuajungco, Zinc and excitotoxic brain injury: a new model, The Neuroscientist 10 (2004), 18-25.
55. Y. Uchida, K. Takio, K. Titani, Y. Ihara and M. Tomonaga, The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein, Neuron 7 (1991), 337-347.
56. J.Y. Lee, J.H. Kim, R.D. Palmiter and J.Y. Koh, Zinc released from metallothionein-III may contribute to hippocampal CA1 and thalamic neuronal death following acute brain injury, Exp Neurol 184 (2003), 337-347.
57. M. Knipp, G. Meloni, B. Roschitzki and M. Vasak, Zn7metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A, Biochemistry 44 (2005), 3159-3165.
58. B. Roschitzki and M. Vasak, A distinct Cu(4)-thiolate cluster of human metallothionein-3 is located in the N-terminal domain, J Biol Inorg Chem 7 (2002), 611-616.
59. A.Q. Truong-Tran, J. Carter, R.E. Ruffin and P.D. Zalewski, The role of zinc in caspase activation and apoptotic cell death, Biometals 14 (2001), 315-330.
60. J.Y. Duffy, C.M. Miller, G.L. Rutschilling, G.M. Ridder, M.S. Clegg, C.L. Keen and G.P. Daston, A decrease in intracellular zinc level precedes the detection of early indicators of apoptosis in HL-60 cells, Apoptosis 6 (2001), 161-172.
61. F.W. Sunderman, Jr., The influence of zinc on apoptosis, Ann Clin Lab Sci 25 (1995), 134-142.
62. P.J. Fraker and W.G. Telford, A reappraisal of the role of zinc in life and death decisions of cells, Proc Soc Exp Biol Med 215 (1997), 229-236.
63. D.K. Perry, M.J. Smyth, H.R. Stennicke, G.S. Salvesen, P. Duriez, G.G. Poirier and Y.A. Hannun, Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis, J Biol Chem 272 (1997), 18530-18533.
64. D.L. Vaux and J. Silke, IAPs, RINGs and ubiquitylation, Nat Rev Mol Cell Biol 6 (2005), 287-297.
65. M.K. Meffert and D. Baltimore, Physiological functions for brain NF-kappaB, Trends Neurosci 28 (2005), 37-43.
66. R.S. Morrison and Y. Kinoshita, The role of p53 in neuronal cell death, Cell Death Differ 7 (2000), 868-879.
67. T. Herdegen and V. Waetzig, AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration, Oncogene 20 (2001), 2424-2437.
68. D. Beyersmann and H. Haase, Functions of zinc in signaling, proliferation and differentiation of mammalian cells, BioMetals 14 (2001), 331-341.
69. W. Maret, Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc, Neurochem Int 27 (1995), 111-117.
70. K. Tanaka, T. Kawakami, K. Tateishi, H. Yashiroda and T. Chiba, Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway, Biochimie 83 (2001), 351-356.
71. T.S. Chang, W. Jeong, D.Y. Lee, C.S. Cho and S.G. Rhee, The RING-H2-finger protein APC11 as a target of hydrogen peroxide, Free Radic Biol Med 37 (2004), 521-530.
72. 2+ dependence, and differential half-site recognition, J Biol Chem 266 (1991), 252-260.
73. J.A. Shumilla, K.E. Wetterhahn and A. Barchowsky, Inhibition of NF-kappa B binding to DNA by chromium, cadmium, mercury, zinc, and arsenite in vitro: evidence of a thiol mechanism, Arch Biochem Biophys 349 (1998), 356-362.
74. R.G. Uzzo, P. Leavis, W. Hatch, V.L. Gabai, N. Dulin, N. Zvartau and V.M. Kolenko, Zinc inhibits nuclear factor-kappa B activation and sensitizes prostate cancer cells to cytotoxic agents, Clin Cancer Res 8 (2002), 3579-3583.
75. P. Connell, V.M. Young, M. Toborek, D.A. Cohen, S. Barve, C.J. McClain and B. Hennig, Zinc attenuates tumor necrosis factor-mediated activation of transcription factors in endothelial cells, J Am Coll Nutr 16 (1997), 411-417.
76. E. Ho and B.N. Ames, Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line, Proc Natl Acad Sci USA 99 (2002), 16770-16775.
77. P.I. Oteiza, M.S. Clegg and C.L. Keen, Short-term zinc deficiency affects nuclear factor-kappab nuclear binding activity in rat testes, J Nutr 131 (2001), 21-26.
78. G.G. Mackenzie, M.P. Zago, C.L. Keen and P.I. Oteiza, Low intracellular zinc impairs the translocation of activated NF-kappa B to the nuclei in human neuroblastoma IMR-32 cells, J Biol Chem 277 (2002), 34610-34617.
79. H. Cao, J.S. Tuttle and P.I. Blackshear, Immunological characterization of tristetraprolin as a low abundance, inducible, stable cytosolic protein, J Biol Chem 279 (2004), 21489-21499.
80. K. Heyninck and R. Beyaert, A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions, Trends Biochem Sci 30 (2005), 1-4.
81. P. Meerarani, G. Reiterer, M. Toborek and B. Hennig, Zinc modulates PPARγ signaling and activation of porcine endothelial cells, J Nutr 133 (2003), 3058-3064.
82. G. Reiterer, M. Toborek and B. Hennig, Peroxisome proliferator activated receptors alpha and gamma require zinc for their anti-inflammatory properties in porcine vascular endothelial cells, J Nutr 134 (2004), 1711-1715.
83. W. Maret, The function of zinc metallothionein: a link between cellular zinc and redox state, J Nutr 130 (2000), 1455S-1458S.
84. W. Maret, The cellular zinc and redox states converge in the metallothionein/thionein pair, J Nutr 133 (2003), 1460S-1462S.
85. C.H. Kim, J.H. Kim, J. Lee and Y.S. Ahn, Zinc-induced NF-kappaB inhibition can be modulated by changes in the intracellular metallothionein level, Toxicol Appl Pharmacol 190 (2003), 189-196.
86. Z. Zhou, L. Wang, Z. Song, J.T. Saari, C.J. McClain and Y.J. Kang, Abrogation of nuclear factor-κB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-α production and liver injury, Am. J Pathol 164 (2004), 1547-1556.
87. H.L. Butcher, W.A. Kennette, O. Collins, R.K. Zalups and J. Koropatnick, Metallothionein mediates the level and activity of nuclear factor kappaB in murine fibroblasts, J Pharmacol Exp Ther 310 (2004), 589-598.
88. Y. Cho, S. Gorina, P.D. Jeffrey and N.P. Pavletich, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science 265 (1994), 346-355.
89. B. Vogelstein, D. Lane and A.J. Levine, Surfing the p53 network, Nature 408 (2000), 307-310.
90. P. Hainaut and K. Mann, Zinc binding and redox control of p53 structure and function, Antioxid Redox Signal 3 (2001), 611-623.
91. E. Ho, C. Courtemanche and B.N. Ames, Zinc deficiency induces oxidative DNA damage and increases p53 expression in human lung fibroblasts, J Nutr 133 (2003), 2543-2548.
92. J.C. Fanzo, S.K. Reaves, L. Cui, L. Zhu, J.Y.J. Wu, Y.R. Wang and K.Y. Lei, Zinc status affects p53, gadd45, and c-fos expression and caspase-3 activity in human bronchial epithelial cells, Am J Physiol Cell Physiol 281 (2001), C751-757.
93. J.C. Fanzo, S.K. Reaves, L. Cui, L. Zhu, J.Y.J. Wu and K.Y. Lei, p53 protein and p21 mRNA levels and caspase-3 activity are altered by zinc status in aortic endothelial cells, Am J Physiol Cell Physiol 283 (2002), C631-C638.
94. C. Meplan, M.J. Richard and P. Hainaut, Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells, Oncogene 19 (2000), 5227-5236.
95. E. Shaulian and M. Karin, AP-1 as a regulator of cell life and death, Nat Cell Biol 4 (2002), E131-136.
96. A. Hansson, Extracellular zinc ions induces mitogen-activated protein kinase activity and protein tyrosine phosphorylation in bombesin-sensitive Swiss 3T3 fibroblasts, Arch Biochem Biophys 328 (1996), 233-238.
97. J.M. Samet, L.M. Graves, J. Quay, L.A. Dailey, R.B. Devlin, A.J. Ohio, W. Wu, P.A. Bromberg and W. Reed, Activation of MAPKs in human bronchial epithelial cells exposed to metals, Am J Physiol 275 (1998), L551-558.
98. 2+-induced ERK activation mediated by reactive oxygen species causes cell death in differentiated PC12 cells, J Neurochem 78 (2001), 600-610.
99. K.S. Park, Y. Ahn, J.A. Kim, M.S. Yun, B.L. Seong and K.Y. Choi, Extracellular zinc stimulates ERK-dependent activation of p21(Cip/WAF1) and inhibits proliferation of colorectal cancer cells, Br J Pharmacol 137 (2002), 597-607.
100. 2+-induced cell death is mediated by the induction of intracellular ROS in ARPE-19 cells, Curr Eye Res 28 (2004), 195-201.
101. J.A. Park and J.Y. Koh, Induction of an immediate early gene egr-1 by zinc through extracellular signal-regulated kinase activation in cortical culture: its role in zinc-induced neuronal death, J Neurochem 73 (1999), 450-456.
102. S.J. Eom, E.Y. Kim, J.E. Lee, H.J. Kang, J. Shim, S.U. Kim, B.J. Gwag and E.J. Choi, Zn(2+) induces stimulation of the c-Jun N-terminal kinase signaling pathway through phosphoinositide 3-kinase, Mol Pharmacol 59 (2001), 981-986.
103. D. Lefebvre, C.M. Boney, J.M. Ketelslegers and J.P. Thissen, Inhibition of insulin-like growth factor-I mitogenic action by zinc chelation is associated with a decreased mitogen-activated protein kinase activation in RAT-1 fibroblasts, FEBS Lett 449 (1999), 284-288.
104. R.S. MacDonald, The role of zinc in growth and cell proliferation, J Nutr 130 (2000), 1500S-1508S.
105. J. Quarterman, C.F. Mills and W.R. Humphries, The reduced secretion of, and sensitivity to insulin in zinc-deficient rats, Biochem Biophys Res Commun 25 (1966), 354-358.
106. X. Tang and N.F. Shay, Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes, J Nutr 131 (2001), 1414-1420.
107. H. Haase and W. Maret, Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants, Biometals (2005), in press.
108. W. Lee, P. Mitchell and R. Tjian, Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements, Cell 49 (1987), 741-752.
109. O. LaRochelle, V. Gagne, J. Charron, J.W. Soh and C. Seguin, Phosphorylation is involved in the activation of metal-regulatory transcription factor 1 in response to metal ions, J Biol Chem 276 (2001), 41879-41888.
110. R.J. Imbra and M. Karin, Metallothionein gene expression is regulated by serum factors and activators of protein kinase C, Mol Cell Biol 7 (1987), 1358-1363.
111. A. Pattanaik, C.F. Shaw III, D.H. Petering, J. Garvey and A.J. Kraker, Basal metallothionein in tumors: widespread presence of apoprotein, J Inorg Biochem 54 (1994), 91-105.
112. L.T. Knapp and E. Klann, Superoxide-induced stimulation of protein kinase C via thiol modification and modulation of zinc content, J Biol Chem 275 (2000), 24136-24145.
113. I. Korichneva, B. Hoyos, R. Chua, E. Levi and U. Hammerling, Zinc release from protein kinase C as the common event during activation by lipid second messenger or reactive oxygen, J Biol Chem 277 (2002), 44327-44331.
114. P. Csermely, M. Szamel, K. Resch and J. Somogyi, Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes, J Biol Chem 263 (1988), 6487-6490.
115. C.Z. Ou and M. Ebadi, Pineal and retinal protein kinase C isoenzyme: Cooperative activation by calcium and zinc metallothionein, J Pineal Res 12 (1992), 17-26.
116. S.S. Chou, M.S. Clegg, T.Y. Momma, B.J. Niles, J.Y. Duffy, G.P. Daston and C.L. Keen, Alterations in protein kinase C activity and processing during zinc-deficiency-induced cell death, Biochem J 383 (2004), 63-71.
117. R.R. Briefel and C.L. Johnson, Secular trends in dietary intake in the United States, Annu. Rev Nutr 24 (2004), 401-431.
118. T. Lu, Y. Pan, S.Y. Kao, C. Li, I. Kohane, J. Chan and B.A. Yankner, Gene regulation and DNA damage in the ageing human brain, Nature 429 (2004), 883-891.